Dosing — 2026-05-08
The Wolverine Stack (BPC-157 + TB-500) is one of the most common peptide combinations in recovery research, and getting the dosing right matters — both peptides are administered subcutaneously at sub-milligram doses, so reconstitution math and unit measurement directly determine whether your protocol matches the published research. This article walks through the practical dosing protocol, the math for both Wolverine 10mg and 20mg vials, the twice-weekly schedule, and the GHK-Cu add-on.
Researcher special: code WELCOME at checkout unlocks 35% off Wolverine 10mg, Wolverine 20mg, the Wolverine Repair Stack (Wolverine + GHK-Cu), bacteriostatic water, and the standalone BPC-157 and TB-500 vials. Every vial ships with a batch-matched COA at 99%+ HPLC purity.
The Wolverine vials are pre-blended:
For an overview of why researchers pair these two compounds, see the Wolverine Stack explained.
Standard reconstitution: 2 mL of bacteriostatic water.
| Metric | Value |
| Total peptide (BPC + TB) | 10 mg (5 + 5) |
| Bac water | 2 mL |
| Total concentration | 5 mg/mL |
| Per 1 unit (U-100 syringe) | 50 mcg total (25 mcg BPC + 25 mcg TB) |
| Per 10 units | 500 mcg total (250 mcg BPC + 250 mcg TB) |
The most common per-dose target is 250 mcg of each compound (= 500 mcg combined = 10 units on a U-100 syringe). At 2× weekly dosing, a single 10mg vial covers about 10 doses, or 5 weeks.
| Units | Volume | Total dose | BPC dose | TB dose |
| 5 units | 0.05 mL | 250 mcg | 125 mcg | 125 mcg |
| 8 units | 0.08 mL | 400 mcg | 200 mcg | 200 mcg |
| 10 units | 0.10 mL | 500 mcg | 250 mcg | 250 mcg |
| 12 units | 0.12 mL | 600 mcg | 300 mcg | 300 mcg |
Standard reconstitution: 2 mL of bacteriostatic water (same volume, double concentration).
| Metric | Value |
| Total peptide (BPC + TB) | 20 mg (10 + 10) |
| Bac water | 2 mL |
| Total concentration | 10 mg/mL |
| Per 1 unit (U-100 syringe) | 100 mcg total (50 mcg BPC + 50 mcg TB) |
| Per 5 units | 500 mcg total (250 mcg BPC + 250 mcg TB) |
For a 250 mcg / 250 mcg target dose, you only need 5 units on the syringe — half the volume of the 10mg vial at the same target dose. A single 20mg vial covers ~20 doses, or about 10 weeks of 2×/week dosing.
The 20mg vial is the most cost-effective choice for protocols longer than 5 weeks.
| Units | Volume | Total dose | BPC dose | TB dose |
| 3 units | 0.03 mL | 300 mcg | 150 mcg | 150 mcg |
| 4 units | 0.04 mL | 400 mcg | 200 mcg | 200 mcg |
| 5 units | 0.05 mL | 500 mcg | 250 mcg | 250 mcg |
| 6 units | 0.06 mL | 600 mcg | 300 mcg | 300 mcg |
For both Wolverine vial sizes, the technique is the same:
For more detail on technique and common reconstitution mistakes, see our reconstitution guide.
The most commonly cited protocol in research summaries:
This protocol uses: - Per dose: 10 units on a U-100 syringe (Wolverine 10mg vial) or 5 units (Wolverine 20mg vial) - Per week: 20 units (10mg vial) or 10 units (20mg vial) - Per 6-week cycle: ~120 units (10mg vial) or ~60 units (20mg vial)
A 6-week cycle uses just over 1 vial of Wolverine 10mg (or about half a vial of Wolverine 20mg).
Some protocols use a loading phase in the first 1–2 weeks at higher frequency:
The loading phase is most commonly used in acute injury research models where rapid signaling onset matters. For longer-term or chronic research designs, skipping the loading phase is fine.
The Wolverine Stack is unusual among research peptides in being well-tolerated for extended cycles. Common cycle structures:
| Endpoint | Cycle |
| Acute injury research | 4 weeks on, then assess |
| General recovery support | 6 weeks on, 4 weeks off |
| Tendon/ligament research | 8–12 weeks on, 6 weeks off |
| Chronic GI research (BPC-dominant) | 8 weeks on, 4 weeks off |
Unlike GH-axis or GP-class peptides, there's minimal receptor desensitization concern with prolonged Wolverine exposure. The off-cycle weeks are more about confirming endpoint stability than restoring receptor function.
BPC-157 has documented localized repair effects, which means proximity matters for research designs targeting a specific tissue:
TB-500 doesn't show the same proximity-dependence — it acts systemically through cell migration and angiogenesis signaling. So in a Wolverine combination, the BPC component is the one whose injection location matters most.
The Wolverine Repair Stack adds GHK-Cu (a copper peptide) to the standard Wolverine protocol. The GHK-Cu adds matrix-remodeling and collagen-synthesis signaling that BPC + TB don't directly target.
The Repair Stack is most commonly used in:
A 6-week Wolverine Stack protocol needs: - 1 vial Wolverine 20mg (or 2 vials Wolverine 10mg) - 1 vial bacteriostatic water 10mL - U-100 insulin syringes
For the Wolverine Repair Stack (with GHK-Cu), add: - 1 vial GHK-Cu 100mg
Code WELCOME at checkout unlocks 35% off Wolverine 10mg, Wolverine 20mg, the Wolverine Repair Stack, GHK-Cu 100mg, bacteriostatic water, and standalone BPC-157 and TB-500 vials. Every vial ships with a batch-matched COA showing 99%+ HPLC purity, US-based handling, and the per-mg potency consistency that makes accurate sub-microgram dosing possible.
Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.